SVB Wealth’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $244K | Buy |
5,714
+2,193
| +62% | +$119K | 0.02% | 353 |
|
|
2026
Q1 | $221K | Sell |
3,521
-828
| -19% | -$66.2K | 0.01% | 364 |
|
|
2025
Q4 | $415K | Sell |
4,349
-2,796
| -39% | -$274K | 0.02% | 293 |
|
|
2025
Q3 | $698K | Sell |
7,145
-243
| -3% | -$25.2K | 0.04% | 261 |
|
|
2025
Q2 | $794K | Buy |
+7,388
| New | +$748K | 0.04% | 249 |
|
|
2025
Q1 | – | Sell |
-11,185
| Closed | -$999K | – | 1527 |
|
|
2024
Q4 | $999K | Buy |
+11,185
| New | +$985K | 0.02% | 320 |
|
|
2024
Q3 | – | Sell |
-11,409
| Closed | -$879K | – | 100 |
|
|
2024
Q2 | $879K | Sell |
11,409
-2,300
| -17% | -$168K | 0.02% | 349 |
|
|
2024
Q1 | $939K | Sell |
13,709
-342
| -2% | -$22K | 0.02% | 359 |
|
|
2023
Q4 | $812K | Buy |
14,051
+1,503
| +12% | +$80.2K | 0.02% | 370 |
|
|
2023
Q3 | $663K | Buy |
12,548
+47
| +0.4% | +$2.46K | 0.01% | 391 |
|
|
2023
Q2 | $676K | Sell |
12,501
-1,620
| -11% | -$84.6K | 0.01% | 414 |
|
|
2023
Q1 | $706K | Sell |
14,121
-3,126
| -18% | -$147K | 0.01% | 452 |
|
|
2022
Q4 | $798K | Sell |
17,247
-50
| -0.3% | -$2.17K | 0.01% | 449 |
|
|
2022
Q3 | $670K | Buy |
17,297
+9,186
| +113% | +$369K | 0.01% | 456 |
|
|
2022
Q2 | $302K | Sell |
8,111
-3,019
| -27% | -$123K | ﹤0.01% | 563 |
|
|
2022
Q1 | $493K | Buy |
11,130
+336
| +3% | +$14.6K | 0.01% | 453 |
|
|
2021
Q4 | $459K | Sell |
10,794
-3,442
| -24% | -$145K | 0.01% | 464 |
|
|
2021
Q3 | $618K | Buy |
14,236
+4,345
| +44% | +$192K | 0.01% | 536 |
|
|
2021
Q2 | $423K | Buy |
9,891
+1,183
| +14% | +$49.8K | 0.01% | 635 |
|
|
2021
Q1 | $337K | Sell |
8,708
-4,314
| -33% | -$163K | ﹤0.01% | 641 |
|
|
2020
Q4 | $469K | Sell |
13,022
-140
| -1% | -$5.05K | 0.01% | 492 |
|
|
2020
Q3 | $503K | Buy |
13,162
+1,202
| +10% | +$46.3K | 0.01% | 402 |
|
|
2020
Q2 | $420K | Buy |
11,960
+1,033
| +9% | +$37.2K | 0.01% | 394 |
|
|
2020
Q1 | $357K | Sell |
10,927
-3,437
| -24% | -$134K | 0.01% | 366 |
|
|
2019
Q4 | $650K | Buy |
14,364
+4,493
| +46% | +$188K | 0.01% | 371 |
|
|
2019
Q3 | $402K | Sell |
9,871
-12,447
| -56% | -$527K | 0.01% | 403 |
|
|
2019
Q2 | $959K | Sell |
22,318
-440
| -2% | -$16.9K | 0.03% | 285 |
|
|
2019
Q1 | $873K | Sell |
22,758
-7
| -0% | -$267 | 0.03% | 235 |
|
|
2018
Q4 | $805K | Buy |
22,765
+35
| +0.2% | +$1.27K | 0.03% | 237 |
|
|
2018
Q3 | $875K | Sell |
22,730
-243
| -1% | -$8.49K | 0.03% | 267 |
|
|
2018
Q2 | $751K | Buy |
22,973
+13,372
| +139% | +$403K | 0.03% | 285 |
|
|
2018
Q1 | $262K | Buy |
9,601
+171
| +2% | +$4.65K | 0.01% | 392 |
|
|
2017
Q4 | $234K | Hold |
9,430
| – | – | 0.01% | 434 |
|
|
2017
Q3 | $275K | Hold |
9,430
| – | – | 0.01% | 405 |
|
|
2017
Q2 | $261K | Sell |
9,430
-764
| -7% | -$20.3K | 0.01% | 422 |
|
|
2017
Q1 | $254K | Sell |
10,194
-10,036
| -50% | -$244K | 0.01% | 427 |
|
|
2016
Q4 | $438K | Sell |
20,230
-2,660
| -12% | -$58K | 0.02% | 366 |
|
|
2016
Q3 | $545K | Buy |
22,890
+85
| +0.4% | +$2.03K | 0.02% | 325 |
|
|
2016
Q2 | $533K | Hold |
22,805
| – | – | 0.02% | 336 |
|
|
2016
Q1 | $429K | Sell |
22,805
-2,000
| -8% | -$35.1K | 0.02% | 378 |
|
|
2015
Q4 | $457K | Sell |
24,805
-4,115
| -14% | -$73.7K | 0.02% | 387 |
|
|
2015
Q3 | $475K | Sell |
28,920
-4,838
| -14% | -$82.7K | 0.02% | 418 |
|
|
2015
Q2 | $598K | Sell |
33,758
-138,112
| -80% | -$2.47M | 0.02% | 408 |
|
|
2015
Q1 | $3.05M | Sell |
171,870
-27,740
| -14% | -$438K | 0.1% | 187 |
|
|
2014
Q4 | $2.65M | Buy |
+199,610
| New | +$2.55M | 0.09% | 201 |
|
Other funds holding BSX
SVB Wealth's BSX Position: Q2 2026 in Review
SVB Wealth increased its Boston Scientific (BSX) stake by 62% in Q2 2026, buying an estimated $119K and bringing the position to 5,714 shares worth $244K. The position accounts for 0.02% of the portfolio, ranked #353.
SVB Wealth first reported a position in BSX in Q4 2014 and has held it in 45 quarters since. The position peaked at $3.05M in Q1 2015. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- SVB Wealth held 5,714 shares of Boston Scientific worth $244K as of Q2 2026.
- SVB Wealth bought 2,193 Boston Scientific shares in Q2 2026, an estimated $119K.
- Boston Scientific made up 0.02% of SVB Wealth's portfolio in Q2 2026, its #353 holding.
- SVB Wealth first reported a position in Boston Scientific in Q4 2014 and has held it in 45 quarters since.
- SVB Wealth's Boston Scientific position peaked at $3.05M in Q1 2015.
- 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on SVB Wealth's 13F filing for Q2 2026, filed 17 Jul 2026.